Gates Foundation Invests in Experimental Cancer Trial.

The Gates Foundation has invested in an experimental cancer trial, marking an unusual move for the philanthropic organization. The trial, which is being conducted by biotech company Tmunity, involves genetically modifying patients' T-cells to target specific cancer cells. The Gates Foundation's investment is part of a larger funding round for Tmunity, which aims to raise $75m to support its medical research.